Utilization of low-field MR scanners

Magnetic Resonance in Medical Sciences

Volumn 3, Issue 1, 2004, Pages 27-38

  Hayashi, Naoto ^a   Watanabe, Yasushi ^a   Masumoto, Tomohiko ^b   Mori, Harushi ^a   Aoki, Shigeki ^b   Ohtomo, Kuni ^a,b   Okitsu, Osamu ^c   Takahashi, Tetsuhiko ^c  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c HITACHI LTD   (Japan)

Author keywords

Cost benefit; Interventional MRI; Low field MRI; MR safety

Indexed keywords

COST BENEFIT ANALYSIS; ECONOMICS; EQUIPMENT; HUMAN; INSTRUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

COST-BENEFIT ANALYSIS; EQUIPMENT SAFETY; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 24344469713     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.3.27     Document Type: Review

References (53)

1. Sepponen RE. Low-field MR imaging-development in Finland. Acta Radiol 1996; 37:446-454.
2. Marti-Bonmati L, Kormano M. MR equipment acquisition strategies: low-field or high-field scanners. Eur Radiol 1997; 7 (Suppl):263-268.
3. Kaufman L. The impact of radiology's culture on the cost of magnetic resonance imaging. J Magn Reson Imaging 1996; 6:67-71.
4. Kent DL, Haynor DR, Longstreth WT, Jr., Larson EB. The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann Intern Med 1994; 120:856-871.
5. Orrison WW, Jr., Stimac GK, Stevens EA, et al. Comparison of CT, low-field-strength MR imaging, and high-field-strength MR imaging. Work in progress. Radiology 1991; 181:121-127.
6. Bradley WG. Future cost-effective MRI will be at high field. J Magn Reson Imaging 1996; 6:63-66.
7. Kuhl CK, Kreft BP, Hauswirth A, et al. MR mammography at 0.5 tesla. I. Comparison of image quality and sensitivity of MR mammography at 0.5 and 1.5 T. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1995; 162:381-389.
8. Kuhl CK, Kreft BP, Hauswirth A, et al. MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1995; 162:482-491.
9. Kent DL, Larson EB. Magnetic resonance imaging of the brain and spine. Is clinical efficacy established after the first decade? Ann Intern Med 1988; 108:402-424.
10. Tung GA, Entzian D, Green A, Brody JM. High-field and low-field MR imaging of superior glenoid labral tears and associated tendon injuries. AJR 2000; 174:1107-1114.
11. Merl T, Scholz M, Gerhardt P, et al. Results of a prospective multicenter study for evaluation of the diagnostic quality of an open whole-body low-field MRI unit. A comparison with high-field MRI measured by the applicable gold standard. Eur J Radiol 1999; 30:43-53.
12. Elster AD. How much contrast is enough? Dependence of enhancement on field strength and MR pulse sequence. Eur Radiol 1997; 7 (Suppl): 276-280.
13. Allmann KH, Walter O, Laubenberger J, et al. Magnetic resonance diagnosis of the anterior labrum and capsule. Effect of field strength on efficacy. Invest Radiol 1998; 33:415-420.
14. Dubrulle F, Delomez J, Kiaei A, et al. Mass screening for retrocochlear disorders: low-field-strength (0.2-T) versus high-field-strength (1.5-T) MR imaging. AJNR 2002; 23:918-923.
15. Spouse E, Gedroyc WM. MRI of the claustrophobic patient: interventionally configured magnets. Br J Radiol 2000; 73:146-151.
16. Evers SR. Anxiety of MR patients extends beyond claustrophobia. Diagn Imaging (San Franc) 1999; 21:41-43, 45, 48.
17. Melendez JC, McCrank E. Anxiety-related reactions associated with magnetic resonance imaging examinations. Jama 1993; 270:745-747.
18. Francis JM, Pennell DJ. Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation. J Cardiovasc Magn Reson 2000; 2:139-141.
19. Berlin L. Sedation and analgesia in MR imaging. AJR 2001; 177:293-296.
20. Hollenhorst J, Munte S, Friedrich L, et al. Using intranasal midazolam spray to prevent claustrophobia induced by MR imaging. AJR 2001; 176:865-868.
21. Sarji SA, Abdullah BJ, Kumar G, Tan AH, Narayanan P. Failed magnetic resonance imaging examinations due to claustrophobia. Australas Radiol 1998; 42:293-295.
22. McIsaac HK, Thordarson DS, Shafran R, Rachman S, Poole G. Claustrophobia and the magnetic resonance imaging procedure. J Behav Med 1998; 21:255-268.
23. Murphy KJ, Brunberg JA. Adult claustrophobia, anxiety and sedation in MRI. Magn Reson Imaging 1997; 15:51-54.
24. Katz RC, Wilson L, Frazer N. Anxiety and its determinants in patients undergoing magnetic resonance imaging. J Behav Ther Exp Psychiatry 1994; 25:131-134.
25. Kanal E. Keep eye on risk and safety issues surrounding MRI. Diagn Imaging (San Franc) 2000; 22:75-77, 79, 81.
26. Sheldon P, Kaufman L, Carlson J. Forces and torques produced by a 640-gauss permanent magnet of ferromagnetic objects. J Neuroimaging 1991; 1:184-190.
27. Lenz G, Drobnitzky M. Interventional MRI with an open low-field system, In: Debatin JF, Adams G, eds. Interventional magnetic resonance imaging. Berlin: Springer-Verlag, 1998; 3-10.
28. Lufkin RB. InterventionalMR imaging. Radiology 1995; 197:16-18.
29. Vogl TJ, Mack MG, Muller PK, Straub R, Engelmann K, Eichler K. Interventional MR: interstitial therapy. Eur Radiol 1999; 9:1479-1487.
30. Jolesz FA. Interventional and intraoperative MRI: a general overview of the field. J Magn Reson Imaging 1998; 8:3-7.
31. Tacke J, Speetzen R. MR-guided cryotherapy, In: Debatin JF, Adams G, eds. Interventional magnetic resonance imaging. Berlin: Springer-Verlag, 1998; 195-201.
32. Wong TZ, Silverman SG, Fielding JR, Tempany CM, Hynynen K, Jolesz FA. Open-configuration MR imaging, intervention, and surgery of the urinary tract. Urol Clin North Am 1998; 25: 113-122.
33. Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 2000; 217: 657-664.
34. Shingleton WB, Sewell PE, Jr. Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. J Urol 2001; 165:773-776.
35. Mala T, Edwin B, Samset E, et al. Magneticresonance-guided percutaneous cryoablation of hepatic tumours. Eur J Surg 2001; 167:610-617.
36. Shingleton WB, Sewell PE, Jr. Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease. J Urol 2002; 167:1268-1270.
37. Dohi M, Harada J, Mogami T, Fukuda K, Toyama Y, Kashiwagi H. MR-guided percutaneous cryotherapy of malignant liver tumor under horizontal-magnetic open system: initial experience. J Hepatobiliary Pancreat Surg 2003; 10:360-365.
38. Harada J, Dohi M, Mogami T, et al. Initial experience of percutaneous renal cryosurgery under the guidance of a horizontal open MRI system. Radiat Med 2001; 19:291-296.
39. Kanner AA, Vogelbaum MA, Mayberg MR, Weisenberger JP, Barnett GH. Intracranial navigation by using low-field intraoperative magnetic resonance imaging: preliminary experience. J Neurosurg 2002; 97:1115-1124.
40. Nimsky C, Ganslandt O, Gralla J, Buchfelder M, Fahlbusch R. Intraoperative low-field magnetic resonance imaging in pediatric neurosurgery. Pediatr Neurosurg 2003; 38:83-89.
41. Nimsky C, Ganslandt O, Hofmann B, Fahlbusch R. Limited benefit of intraoperative low-field magnetic resonance imaging in craniopharyngioma surgery. Neurosurgery 2003; 53:72-80.
42. Levivier M, Wikler D, De Witte O, Van de Steene A, Baleriaux D, Brotchi J. PoleStar N-10 low-field compact intraoperative magnetic resonance imaging system with mobile radiofrequency shielding. Neurosurgery 2003; 53:1001-1006.
43. Schulder M, Azmi H, Biswal B. Functional magnetic resonance imaging in a low-field intraoperative scanner. Stereotact Funct Neurosurg 2003; 80:125-131.
44. Nimsky C, Ganslandt O, Tomandl B, Buchfelder M, Fahlbusch R. Low-field magnetic resonance imaging for intraoperative use in neurosurgery: a 5-year experience. Eur Radiol 2002; 12:2690-2703.
45. Nimsky C, Ganslandt O, Buchfelder M, Fahlbusch R. Glioma surgery evaluated by intraoperative low-field magnetic resonance imaging. Acta Neurochir Suppl 2003; 85:55-63.
46. Bohinski RJ, Warnick RE, Gaskill-Shipley MF, et al. Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery. Neurosurgery 2001; 49:1133-1143.
47. Grenier N, Rinck PA. "Controversial issues". Summary of the third session. MRI contrast media: new developments and trends. Symposium. Eur Radiol 1997; 7 (Suppl 5):253-255.
48. Araki T, Aoki S, Ishigame K, et al. MR-guided intravascular catheter manipulation: feasibility of both active and passive tracking in experimental study and initial clinical applications. Radiat Med 2002; 20:1-8.
49. Buecker A, Adam GB, Neuerburg JM, et al. Simultaneous real-time visualization of the catheter tip and vascular anatomy for MR-guided PTA of iliac arteries in an animal model. J Magn Reson Imaging 2002; 16:201-208.
50. Bakker CJ, Hoogeveen RM, Weber J, van Vaals JJ, Viergever MA, Mali WP. Visualization of dedicated catheters using fast scanning techniques with potential for MR-guided vascular interventions. Magn Reson Med 1996; 36:816-820.
51. Masumoto T, Hayashi N, Mori H, et al. Development of intraarterial contrast-enhanced 2D MRDSA with a 0.3 tesla open MRI system. Magn Reson Med Sci 2003; 2:97-103.
52. Hayashi N, Masumoto T, Okubo T, et al. Hemangiomas in the face and extremities: MR-guided sclerotherapy optimization with monitoring of signal intensity changes in vivo. Radiology 2003; 226:567-572.
53. Mori H, Hayashi N, Aoki S, et al. Selective intraarterial infusion chemotherapy using a combined MRI-angiography system for head and neck cancers. Nippon Igaku Hoshasen Gakkai Zasshi 2002; 62:32-34.